370
Participants
Start Date
October 2, 2020
Primary Completion Date
May 11, 2022
Study Completion Date
September 24, 2025
Monalizumab
Participants will receive IV infusion of monalizumab as stated in arm description.
Cetuximab
Participants will receive IV infusion of cetuximab as stated in arm description.
Placebo
Participants will receive IV infusion of placebo as stated in arm description.
Research Site, Taipei
Research Site, Taipei
Research Site, Changhua
Research Site, Tainan City
Research Site, Manila
Research Site, Quezon City
Research Site, Brussels
Research Site, CABA
Research Site, Sofia
Research Site, Pasig
Research Site, Camperdown
Research Site, Melbourne
Research Site, Leuven
Research Site, Bern
Research Site, Heidelberg
Research Site, Plovdiv
Research Site, Linz
Research Site, Basel
Research Site, Panagyurishte
Research Site, Namur
Research Site, Elizabeth Vale
Research Site, Roeselare
Research Site, New York
Research Site, Candiolo
Research Site, Goyang-si
Research Site, Athens
Research Site, Berlin
Research Site, Marseille
Research Site, Seongnam-si
Research Site, Pittsburgh
Research Site, Philadelphia
Research Site, Philadelphia
Research Site, Milan
Research Site, Milan
Research Site, Dijon
Research Site, Brescia
Research Site, Winston-Salem
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Charlotte
Research Site, Cheongju-si
Research Site, Hanover
Research Site, Bordeaux
Research Site, Montpellier
Research Site, Padua
Research Site, Taichung
Research Site, Taichung
Research Site, Modena
Research Site, Columbus
Research Site, Essen
Research Site, Valencia
Research Site, Ann Arbor
Research Site, Busan
Research Site, Florence
Research Site, Thessaloniki
Research Site, Rochester
Research Site, Chicago
Research Site, Clermont-Ferrand
Research Site, St Louis
Research Site, Westwood
Research Site, Strasbourg
Research Site, Lyon
Research Site, Dallas
Research Site, Houston
Research Site, Freiburg im Breisgau
Research Site, Napoli
Research Site, Avignon
Research Site, Tucson
Research Site, Ulm
Research Site, Las Vegas
Research Site, Würzburg
Research Site, Moscow
Research Site, Moscow Region
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Obninsk
Research Site, Boston
Research Site, CABA
Research Site, CABA
Research Site, Belo Horizonte
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, São Paulo
Research Site, São Paulo
Research Site, São Paulo
Research Site, Victoria
Research Site, Hamilton
Research Site, Toronto
Research Site, Toronto
Research Site, Montreal
Research Site, Leipzig
Research Site, Chaïdári
Research Site, Chūōku
Research Site, Fukuoka
Research Site, Hiroshima
Research Site, Isehara-shi
Research Site, Kashiwa
Research Site, Kobe
Research Site, Kōtoku
Research Site, Okayama
Research Site, Sayama
Research Site, Sunto-gun
Research Site, Yokohama
Research Site, Yokohama
Research Site, Amsterdam
Research Site, Maastricht
Research Site, Nijmegen
Research Site, Bialystok
Research Site, Bydgoszcz
Research Site, Poznan
Research Site, Coimbra
Research Site, Porto
Research Site, Porto
Research Site, Vila Nova de Gaia
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Lausanne
Research Site, London
Research Site, Manchester
Research Site, Newcastle upon Tyne
Research Site, Sutton
Lead Sponsor
Collaborators (1)
Innate Pharma
INDUSTRY
AstraZeneca
INDUSTRY